Russia claims to have completed human trials of the COVID-19 vaccine. Production to begin by September-Technology News, Firstpost

Abigail BanerjeeAugust 6, 2020 17:24:54 IS

Six candidates from around the world are currently in the third phase of human trials in a race to find a vaccine that protects people from the new coronavirus. A recent report from Russia said one candidate had successfully completed all three phases of a human clinical trial. Russia is reported to soon start producing vaccines and already has a large nationwide vaccination program.

There are currently two COVID-19 vaccine candidates in Russia. The first is a vaccine being developed by the Vektor State Research Center of Virology and Biotechnology. The second is a vaccine manufactured by the Gamaleya Institute of Epidemiology and Microbiology along with the Russian Ministry of Defense.

As of August 1, Tas Gama-COVID-Vac Lyo, a vaccine candidate from the Gamaleya Scientific Research Institute, is reportedly undergoing human trials. The vaccine registration process will begin from August 10th to 12th. The vaccine will then be available within 3-7 days of registration. Bloomberg To report.

“Clinical trials of the coronavirus vaccine developed by the Gamalaya Center have been completed and work is underway to register the vaccine,” said Russian Health Minister Mikhail Murashko in a report.

The human test of Gam-COVID-Vac Lyo, a vaccine candidate of Gamaleya Scientific Research Institute, has been completed.

Tas Kirill Dmitriev, head of the Russian Direct Investment Fund (RDIF), reported that people injected with Gam-COVID-Vac Lyo developed immunity 21 days after receiving the first dose. He said their immunity had doubled after they received their second injection.

“In Phases 1 and 2, 100% of people develop immunity after day 21. It doubles after the second. 100% of animals also (for new coronaviruses ) Protected” Dmitriev said..

But it was only July 13 that Russia was reported claiming to be their claim. Phase I trial with two parts wAs a success.

World Health Organization Tracking various COVID-19 candidates It also does not mention vaccines that clear all three phases of human trials. Russian medical professionals Corner cut and fast tracking The process of putting people at risk. WHO has also intervened and called on the country to follow established guidelines for producing “safe and effective vaccines”.

WHO spokesman Christian Lindmeyer said At a press conference“Sometimes individual researchers claim to have discovered something, which is, of course, great news in itself. But finding a vaccine that works or getting a clue, and all There is a big difference between going through the stages.”

Dr. Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases I was careful“I hope China and Russia are actually testing the vaccine before giving it to anyone.”

August 2, Russian public health chief Anna Popova’s chief Said in an interview To Russia-1 TV channel, “I got a vaccine [against the novel coronavirus] It’s absolutely safe to reach people, and, of course, efficient. “

“I, [immunity] It will be sustainable and lasting,” she added.

Russian Defense Ministry Intervened to clarify It is “testing volunteer vaccines in full compliance with legislative and scientific methodological legislation to prevent further risks without attempting to shorten the study period.”

Beginning vaccine manufacturing

Ah Reuters Citing an anonymous source, the report said Russia’s first potential vaccine will be approved by regulators this month. All production of this vaccine will begin in September.

Industry and Trade Minister Denis Manturov said in an interview with Tas “The Gamaraya Institute is committed to serial production with three companies equipped in Vladimir, Yaroslavl and the Moscow region. These are the Generalium, R Farm and Vinno Farm… Also strongly hopes to start in September.”

Exact numbers aren’t given, but Mantulov said that “thousands of times each year” would be generated monthly each year. By 2021, Russian companies will produce “millions” doses of vaccines from the National Institute of Epidemiology and Microbiology, Gamaleye.

Illustration of a COVID-19 vaccine vial. Image credit: Flickr / Jernej Furman

In an interview with Dmitriev, Rossiya-24 TV The channel said more than 20 countries from all over the world are interested in producing Russian vaccines.

“Our foreign partners have shown great interest in producing this vaccine in this country. From Brazil, India, and others very excited about the Russian vaccine, the world’s first vaccine.” There is great interest from countries,” Dmitriev said. Tas..

“And now more than five countries are actively working with us to start producing Russian vaccines,” he added.

Mass vaccination by October

On August 1, Health Minister Murashko said Russia would launch a mass vaccination campaign against the new coronavirus in October. According to the report Live mint, The vaccine is given first to doctors and teachers.

“Wide plan [vaccination] We need to start a new treatment system gradually, so in October.” Tas..

The vaccine is also “free” and the cost is taken from the national budget.

Vector vaccine

The EpiVac Corona vaccine, manufactured by the Vektor State Research Center, and federal service biotechnology for consumer rights protection and human health surveillance have recently been Start mass production Of the vaccine for November.

As of 24 July and 4 August 2020, 3 out of 5 volunteers Yesterday, on August 5, a fifth volunteer was vaccinated for the first dose. Ages from 18-30 years old. The dose of EpiVac Corona will be given again 21 days later.

According to the federal service for the protection of consumer rights and the monitoring of human well-being, Russia is developing 26 additional coronavirus vaccine candidates at 17 research institutions. Within the next six to eight weeks, Murashco said the developers of the other two vaccines will submit a permit application to begin clinical trials in volunteers.

Also read:

Cozy Bear: Everything We Know About Hackers Targeting COVID-19 Vaccine Research

Russian COVID-19 Vaccine Successfully Completes First Phase of Human Clinical Trials